miR-92a-3p西

Romain Larrue1, Sandy Fellah1, Nihad Boukrout1

  • 1University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.

Cell death & disease
|September 13, 2023
PubMed
概括

向miR-92a-3p可以提高KRAS突变肺腺癌中西斯普拉丁的敏感性. 沉默这种微RNA会增加癌细胞对化疗的敏感性,为耐火性瘤提供了一种新的策略.